Table 4 Patient and physician reported outcome measures
| Â | Study Group | Group Comparisonsa | ||||
|---|---|---|---|---|---|---|
OA | Gout | RA | OA vs. Gout | OA vs. RA | Gout vs. RA | |
Number of available data (n) | 25 | 8 | 7 | Â | Â | Â |
Joint effusion | ||||||
 Not at all | 8 (32.0%) | 1 (12.5%) | 0 (0.0%) | 0.001 |  < 0.001 | 0.506 |
 Minimal | 14 (56.0%) | 0 (0.0%) | 0 (0.0%) | |||
 Moderate | 3 (12.0%) | 6 (75.0%) | 5 (71.4%) | |||
 Severe | 0 (0.0%) | 1 (12.5%) | 2 (28.6%) | |||
Patient assessment of knee pain (mm) | 67.5 (56.5–77.0) | 82.0 (70.5–96.5) | 71.5 (53.0–88.0) | 0.229 | 0.688 | 0.62 |
Patient global assessment (mm) | 67.5 (48.0–78.0) | 71.5 (43.5–83.0) | 73.5 (46.0–79.5) | 0.686 | 0.686 | 1.00 |
Early morning stiffness (minutes) | 10.0 (5.0–30.0) | 20.0 (0.0–40.0) | 37.5 (5.0–60.0) | 0.26 | 0.429 | 0.61 |
Physician global assessment of severity (mm) | 51.5 (43.0–61.0) | 50.0 (43.5–67.0) | 53.5 (49.0–80.0) | 0.686 | 0.686 | 1.00 |